Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model
IntroductionChemotherapy remains the mainstay treatment for triple-negative breast cancer (TNBC) due to the lack of specific targets. Given a modest response of immune checkpoint inhibitors in TNBC patients, improving immunotherapy is an urgent and crucial task in this field. CD73 has emerged as a n...
Main Authors: | Karan Mediratta, Sara El-Sahli, Marie Marotel, Muhammad Z. Awan, Melanie Kirkby, Ammar Salkini, Reem Kurdieh, Salman Abdisalam, Amit Shrestha, Chiara Di Censo, Andrew Sulaiman, Sarah McGarry, Jessie R. Lavoie, Zhen Liu, Seung-Hwan Lee, Xuguang Li, Giuseppe Sciumè, Vanessa M. D’Costa, Michele Ardolino, Lisheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1366197/full |
Similar Items
-
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
by: Karan Mediratta, et al.
Published: (2020-11-01) -
Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
by: Andrew Sulaiman, et al.
Published: (2020-08-01) -
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
by: Andrew Sulaiman, et al.
Published: (2019-08-01) -
Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
by: Frederic St-Denis-Bissonnette, et al.
Published: (2022-01-01) -
Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
by: Sara El-Sahli, et al.
Published: (2020-11-01)